RaQualia Pharma Inc. (TYO:4579)
Japan · Delayed Price · Currency is JPY 623.00
+16.00 (2.64%)
Oct 6, 2026, 3:30 PM JST
RaQualia Pharma Market Cap
RaQualia Pharma has a market cap or net worth of 15.8 billion as of October 5, 2026. Its market cap has increased by 9.50% in one year.
Market Cap
15.80B
Enterprise Value
13.79B
Revenue
3.90B
Ranking
n/a
PE Ratio
95.96
Stock Price
623.00
ChartMarket Cap Chart
Since July 20, 2011, RaQualia Pharma's market cap has decreased from 19.90B to 15.80B, a decrease of -20.60%. That is a compound annual growth rate of -1.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 15.80B | -36.03% |
| Dec 30, 2025 | 24.70B | 194.57% |
| Dec 30, 2024 | 8.39B | -43.62% |
| Dec 29, 2023 | 14.87B | -42.44% |
| Dec 30, 2022 | 25.84B | 5.05% |
| Dec 30, 2021 | 24.60B | 17.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innovacell | 26.19B |
| Stella Pharma | 16.89B |
| CanBas | 14.66B |
| AnGes | 14.36B |
| ReproCELL | 14.22B |
| Immuno-Biological Laboratories | 10.77B |
| Kubota Pharmaceutical Holdings | 10.54B |
| StemRIM | 10.34B |